HOTEL INFO: please call us to assist with your reservation

Royalton St. Lucia Resort $265 per person per night Junior Suite or $339 per person per night Junior Suite Ocean View based on double occupancy. Single and triple rates are available as well as children rates. ALL-INCLUSIVE= accommodations, all meals and snacks, all drinks (alcoholic or non-alcoholic), all entertainment.

Mandatory to stay at this resort if attending seminars

www.royaltonresorts.com/resorts/st-lucia

Dr. Stan Louie, Pharm D.

University of Southern California

Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C.  In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.

Friday November 15, 2024

ADVANCES IN THE TREATMENT OF HEPATITIS B & C

ACPE# TBA

Objectives:

1.  Explain the risk factors of Hepatitis B & C
2.  Develop a pharmaceutical care plan that will effectively manage patients with either Hepatitis B or C infections.
3.  Identify the classes of pharmaceutical agents that are active against Hepatitis B or C.
4.  Be able to manage drug-induced toxicity associated with the treatment of Hepatitis B or C.

—————————————————————————————————————————————————————————————————————————————

Saturday November 16, 2024

ADVANCES IN CANCER THERAPY

ACPE# TBA

Objectives:

1.  Understand how cancer emerges from normal host replication process.
2.  Understand how cancer proliferates, progresses and leads to metastatic diseases.
3.  Identify conventional agents for various solid tumors (e.g. colon, breast, urologic, and brain cancers).
4.  Describe how new kinase inhibitors are able to inhibit cancer progression.
5.  Describe how new anti-angiogenesis agents would prevent the progression of cancer proliferation.
6.  Understand the types of adverse events that patients may encounter when receiving these types of anti-cancer agents.
7.  Be able to convey to patients methods to ameliorate these adverse events.

—————————————————————————————————————————————————————————————————–

Sunday November 17, 2024

ADVANCES IN HIV THERAPY

ACPE # TBA

Objectives:

1.  Review and identify the mechanisms of HIV infection and targets for pharmacotherapy.
2.  Compare and contrast mechanisms of action of various antiretroviral agents.
3.  Identify both clinical and laboratory values advocating the initiation of antiretroviral therapy.
4.  Identify new agents in the fight against HIV and how they fit into the currently available agents.
5.  Explain the antiviral effects associated with high active antiretroviral therapy (HAART).
6.  Identify and manage possible drug-drug interactions between antiretroviral agents with other therapeutic agents.
7.  Explain how to manage various adverse effects associated with antiretroviral agents.